Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TPIV
DateTimeSourceHeadlineSymbolCompany
19/10/201822:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201821:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201821:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201821:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201821:33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
19/10/201821:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:50Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
18/10/201821:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201821:02Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201821:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201816:45PR Newswire (US)TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And FinancingNASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201813:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201813:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201813:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201813:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
17/10/201813:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201821:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
10/10/201811:30PR Newswire (US)TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...NASDAQ:TPIVMarker Therapeutics (delisted)
25/09/201822:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPIVMarker Therapeutics (delisted)
 Showing the most relevant articles for your search:NASDAQ:TPIV